Evommune, Inc. (EVMN)

CIK 2044725 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Evommune, Inc..

Recent SEC filings

FiledFormAccession number
Sep 9, 2026424B30001193125-26-385431
Sep 9, 20268-K0001193125-26-385430
Aug 14, 2026SCHEDULE 13G0000080255-26-000581
Aug 14, 2026SCHEDULE 13G/A0001757283-26-000018
Aug 6, 2026424B30001193125-26-338017
Aug 6, 202610-Q0001193125-26-337984
Aug 6, 20268-K0001193125-26-337964
Jul 30, 20268-K0001193125-26-324972
Jul 16, 2026SCHEDULE 13G0000919574-26-004453
Jul 10, 202640001757072-26-000007
Jul 8, 202640001290976-26-000004
Jun 29, 20268-K0001193125-26-286918
Jun 29, 2026424B30001193125-26-286924
Jun 24, 202640001620548-26-000007
Jun 24, 202640002091053-26-000005
Jun 24, 202640002092017-26-000007
Jun 22, 20261440001950047-26-006381
Jun 3, 202640001347383-26-000003
Jun 3, 202640001620548-26-000005
Jun 3, 202640001290976-26-000002
Jun 3, 202640002092017-26-000005
Jun 3, 202640001216994-26-000003
Jun 2, 20268-K0001193125-26-253482
Jun 2, 20261440001950047-26-005513
Jun 2, 2026424B30001193125-26-253489